Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Trajan Group.
RELATED STOCKHEAD STORIES
News
Market Highlights: Wall Street defies Powell’s hawkish comments; and 5 stocks to watch on the ASX today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers love these ASX listed automotive and scientific instrument stocks
Health & Biotech
ASX Health Stocks: Trajan delivers another strong half as it upgrades guidance
News
Top 10 at 10: The ASX stocks sprinting and stumbling in early trade Monday
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Health & Biotech
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise
Health & Biotech
ASX Health Stocks: Kazia Therapeutics gets crucial designation status from the US FDA
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Mesoblast responds to questions arising from US FDA meeting
News
Closing Bell: December on track to be the ASX’s second best month of 2021
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
News
Closing Bell: ASX rallies 1.25pc as omicron fears continue to subside
Health & Biotech